Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Camprodon-Gomez M"'
Autor:
Castillo-Ribelles L; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain., Arranz-Amo JA; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Hernández-Vara J; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Samaniego-Toro D; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Enriquez-Calzada S; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Pozo SL; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London WC1N 3BG, U.K., Camprodon-Gomez M; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Unit of Hereditary Metabolic Disorders, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Laguna A; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Gonzalo MA; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Ferrer R; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain., Martinez-Vicente M; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Carnicer-Caceres C; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.
Publikováno v:
Analytical chemistry [Anal Chem] 2024 Aug 06; Vol. 96 (31), pp. 12875-12882. Date of Electronic Publication: 2024 Jul 24.
Autor:
Stanescu S; Pediatric Metabolic Unit, Hospital Universitario Ramón y Cajal, European Reference Center (MetabERN), 28034 Madrid, Spain., Correcher Medina P; Pediatric Nutrition and Metabolic Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain., Del Castillo FJ; Genetics Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain., Alonso Luengo O; Pedriatic Unit, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain., Arto Millan LM; Internal Medicine Unit, Complejo Asistencial Universitario de León, 24008 León, Spain., Belanger Quintana A; Pediatric Metabolic Unit, Hospital Universitario Ramón y Cajal, European Reference Center (MetabERN), 28034 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain., Camprodon Gomez M; Rare and Metabolic Diseases Unit, Hospital Universitario Vall d'Hebron, 08035 Barcelona, Spain., Diez Langhetée L; Minority Diseases Unit, Hospital de Manises, 46940 Valencia, Spain., Garcia Campos O; Pediatric Neurology Unit, Hospital Universitario de Toledo, 45007 Toledo, Spain., Matas Garcia A; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.; Muscle Research Unit, Internal Medicine Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain., Perez-Moreno J; Pedriatic Unit, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain., Rubio Gribble B; Pedriatic Unit, Hospital Universitario de Getafe, 28905 Madrid, Spain., Visa-Reñé N; Pedriatic Unit, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain., Giraldo-Castellano P; Fundación Española Para el Estudio y Terapéutica de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), 50006 Zaragoza, Spain., O'Callaghan Gordo M; Neurology Unit and Congenital Metabolic Diseases Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Publikováno v:
Biomedicines [Biomedicines] 2023 Oct 22; Vol. 11 (10). Date of Electronic Publication: 2023 Oct 22.
Autor:
Carnicer-Cáceres C; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: clara.carnicer@vallhebron.cat., Villena-Ortiz Y; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: yolanda.villena@vallhebron.cat., Castillo-Ribelles L; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: laura.castillo@vallhebron.cat., Barquín-Del-Pino R; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: raquel.barquin@vallhebron.cat., Camprodon-Gomez M; Department of Internal Medicine, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: maria.camprodon@vallhebron.cat., Felipe-Rucián A; Department of Pediatric Neurology, Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain. Electronic address: ana.felipe@vallhebron.cat., Moreno-Martínez D; Department of Internal Medicine, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: david.morenomartinez@nhs.net., Lucas-Del-Pozo S; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Neurology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Hernández-Vara J; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Neurology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: jorge.hernandez@vallhebron.cat., García-Serra A; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: anna.garcia@vhir.org., Tigri-Santiña A; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: atigri@vhebron.net., Moltó-Abad M; Functional Validation & Preclinical Research, Drug Delivery & Targeting Group, CIBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain. Electronic address: marc.molto@vhir.org., Agraz-Pamplona I; Department of Nephrology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: irene.agraz@vallhebron.cat., Rodriguez-Palomares JF; Department of Cardiology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: josefernando.rodriguez@vallhebron.cat., Limeres-Freire J; Department of Cardiology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: javier.limeres@vallhebron.cat., Macaya-Font M; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: marc.macaya@vhebron.net., Rodríguez-Sureda V; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemistry and Molecular Biology Research Centre for Nanomedicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: virodriguez@clinic.cat., Miguel LD; Department of Pediatric Neurology, Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain. Electronic address: lucy.dougherty@vhir.org., Del-Toro-Riera M; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Department of Pediatric Neurology, Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain. Electronic address: mireia.deltoro@vallhebron.cat., Pintos-Morell G; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain; Functional Validation & Preclinical Research, Drug Delivery & Targeting Group, CIBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain. Electronic address: guillem.pintos@vhir.org., Arranz-Amo JA; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: joseantonio.arranz@vallhebron.cat.
Publikováno v:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2023 Jan; Vol. 98, pp. 102704. Date of Electronic Publication: 2022 Oct 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lucas-Del-Pozo S; Neurodegenerative Diseases Research Group Vall Hebron Research Institute, Vall Hebron University Hospital Barcelona Spain.; Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London United Kingdom., Moreno-Martinez D; Rare Diseases and Inborn Errors of Metabolism in Adult Unit Vall Hebron University Hospital Barcelona Spain.; Lysosomal Storage Disorders Unit The Royal Free Hospital NHS Foundation Trust and University College London London United Kingdom., Camprodon-Gomez M; Rare Diseases and Inborn Errors of Metabolism in Adult Unit Vall Hebron University Hospital Barcelona Spain., Moreno-Martinez D; Department of Radiology Vall Hebron University Hospital Barcelona Spain., Hernández-Vara J; Neurodegenerative Diseases Research Group Vall Hebron Research Institute, Vall Hebron University Hospital Barcelona Spain.; Department of Neurology Vall Hebron University Hospital Barcelona Spain.
Publikováno v:
Movement disorders clinical practice [Mov Disord Clin Pract] 2021 Sep 03; Vol. 8 (Suppl 1), pp. S37-S39. Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).
Autor:
Friedman J; Department of Neurosciences and Pediatrics University of California Los Angeles California USA.; Department of Neurology Rady Children's Hospital Encinitas California USA.; Rady Children's Institute for Genomic Medicine San Diego California USA., Lucas-Del-Pozo S; Neurodegenerative Diseases Research Group, Vall Hebron Research Institute Vall Hebron University Hospital Barcelona Spain.; Department of Clinical and Movement Neurosciences University College London Queen Square Institute of Neurology London United Kingdom., Moreno-Martinez D; Lysosomal Storage Disorders Unit Royal Free Hospital National Health Service Foundation Trust and University College London London United Kingdom., Camprodon-Gomez M; Rare Diseases and Inborn Errors of Metabolism Unit Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona Barcelona Spain., Moreno-Martinez D; Neuroradiology Department Vall Hebron University Hospital Barcelona Spain., Hernandez-Vara J; Neurodegenerative Diseases Research Group, Vall Hebron Research Institute Vall Hebron University Hospital Barcelona Spain.; Department of Neurology Vall Hebron University Hospital Barcelona Spain., Kurian MA; Developmental Neurosciences, Zayed Centre for Research into Rare Diseases in Children Great Ormond Street Institute of Child Health, UCL London United Kingdom.
Publikováno v:
Movement disorders clinical practice [Mov Disord Clin Pract] 2021 Sep 03; Vol. 8 (Suppl 1), pp. S40-S41. Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).
Autor:
Carnicer-Cáceres C; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Arranz-Amo JA; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Cea-Arestin C; Laboratory of Inborn Errors of Metabolism, Laboratoris Clínics, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Camprodon-Gomez M; Department of Internal Medicine, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Moreno-Martinez D; Department of Internal Medicine, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London WC1E 6BT, UK., Lucas-Del-Pozo S; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Department of Neurology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK., Moltó-Abad M; Functional Validation & Preclinical Research, Drug Delivery & Targeting Group, CIBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain., Tigri-Santiña A; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Agraz-Pamplona I; Department of Nephrology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Rodriguez-Palomares JF; Department of Cardiology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Hernández-Vara J; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Department of Neurology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Armengol-Bellapart M; Neurodegenerative Diseases Laboratory, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Department of Neurology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Del-Toro-Riera M; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Department of Pediatric Neurology, Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain., Pintos-Morell G; Unit of Hereditary Metabolic Disorders, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Functional Validation & Preclinical Research, Drug Delivery & Targeting Group, CIBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2021 Apr 13; Vol. 10 (8). Date of Electronic Publication: 2021 Apr 13.
Autor:
Gervas-Arruga, Javier1 (AUTHOR) javier.gervas@takeda.com, Barba-Romero, Miguel Ángel2,3 (AUTHOR) mabarbar@sescam.jccm.es, Fernández-Martín, Jorge Julián4 (AUTHOR) julianfernandezmartin58@gmail.com, Gómez-Cerezo, Jorge Francisco5,6 (AUTHOR) jfrancisco.gomez@salud.madrid.org, Segú-Vergés, Cristina7 (AUTHOR) cristina.segu@anaxomics.com, Ronzoni, Giacomo8 (AUTHOR) giacomo.ronzoni@takeda.com, Cebolla, Jorge J.8 (AUTHOR) jorge-javier.cebolla@takeda.com
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10329. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.